InsidersTradesSigma
Track the 제노텍 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 제노텍 has published 12 reports. The latest transaction was filed on 9 February 2026 (Sale). Among the most active insiders: 김재종. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
Genotech is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.